An analysis of insured patients with both type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD) identified gaps in care that contribute to poor outcomes and greater morbidity. The study was published in January 2021 in the Journal of the American Heart Association.